Annim Mohammad
Overview
Explore the profile of Annim Mohammad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohammad A, Saini B, Badcock C, Chaar B
Int J Pharm Pract
. 2022 May;
30(4):332-341.
PMID: 35640494
Objectives: The objective of this study is to develop and user-test the comparative effectiveness of two enhanced label designs to improve comprehension of patients with low English proficiency versus a...
2.
Mohammad A, Saini B, Chaar B
Int J Clin Pharm
. 2021 Jun;
43(6):1563-1573.
PMID: 34076804
Background There has been no in depth published study to date reporting on community pharmacists' current experiences and their future practice needs relating to providing culturally competent pharmaceutical care to...
3.
Fabbri A, Hansen Nejstgaard C, Grundy Q, Bero L, Dunn A, Mohammad A, et al.
J Gen Intern Med
. 2021 May;
37(2):290-297.
PMID: 34037923
Background: Few studies have investigated the relationship between industry funding/conflicts of interest and authors' positions in opinion pieces on drug safety. Harmful effects of varenicline, a treatment for smoking cessation,...
4.
Hooimeyer A, Bhasale A, Perry L, Fabbri A, Mohammad A, McEwin E, et al.
Pharmacol Res Perspect
. 2020 Nov;
8(6):e00680.
PMID: 33169534
Information on rare adverse effects is often limited when a medication is initially approved for marketing. Medicines regulators use safety advisories to warn health professionals and consumers about emerging harms....
5.
Fabbri A, OKeeffe M, Moynihan R, Mollebaek M, Mohammad A, Bhasale A, et al.
Br J Clin Pharmacol
. 2020 Feb;
86(7):1416-1429.
PMID: 32067255
Aims: Drug regulators issue safety advisories to warn clinicians and the public about new evidence of harmful effects of medicines. It is unclear how often these messages are covered by...
6.
Mohammad A, Saini B, Chaar B
Res Social Adm Pharm
. 2015 Jan;
11(4):545-59.
PMID: 25618770
Background: Low health literacy may result in adverse health outcomes for patients and is a problem faced by countries with multi-ethnic demography. For those of culturally and linguistically diverse (CALD)...
7.
Mohammad A, Hanrahan J, Sainsbury E, Chaar B
Int J Clin Pharm
. 2012 Jan;
34(2):330-41.
PMID: 22252774
Objective: To explore the opinions and knowledge of Australian pharmacists about impairment in the profession, and their awareness of new legislation regarding impairment and mandatory reporting. Setting: Pharmacy practice in...